Patents Represented by Attorney Flehr Honbach Test Albritton & Herbert LLP
  • Patent number: 5876787
    Abstract: A process of manufacturing a porous carbon material and a capacitor having the same is provided. The process is comprised of: forming an intermediate blank (in the shape of a desired electrode) made of a metal carbide material having a porosity in the range of substantially 30% to 50% by volume. The blank is then impregnated by exposure to a gaseous hydrocarbon mixture at a temperature exceeding the decomposition of the hydrocarbon until the mass of the blank increases by about 10% to 25%. Next the inner surface of the blank is activated by heating. The blank is then exposed to gaseous chlorine and heated to remove the metal and form the blank having transport channels. Further chlorination occurs which forms nano sized pores in the structure. Thus, a porous carbon material is made which contains transport channels and nano sized pores.
    Type: Grant
    Filed: November 8, 1996
    Date of Patent: March 2, 1999
    Assignee: Alfar International, Ltd.
    Inventors: Robert Gustavovitj Avarbz, Alla Vladilenovna Vartanova, Sergej Konstantinovitj Gordeev, Sergej Germanovitj Zjukov, Boris Aleksandrovitj Zelenov, Aleksandr Efimovitj Kravtjik, Viktor Petrovitj Kuznetsov, Julia Aleksandrovna Kukusjkina, Tatjana Vasilevna Mazaeva, Olga Sergeevna Pankina, Vasilij Vasilevitj Sokolov
  • Patent number: 5834017
    Abstract: Improved oral cyclosporin formulations which have high bioavailability and are capable of administration in hard capsules, are provided. In the subject formulations, cyclosporin is delivered in an orally acceptable vehicle comprising at least one alkanol of from 2 to 3 carbon atoms in combination with at least one non-ionic surfactant and an ester of an alcohol and a fatty acid having a hydrocarbon chain of from 14 to 18 carbon atoms. The subject formulations find use in immunosuppressive therapy.
    Type: Grant
    Filed: August 25, 1995
    Date of Patent: November 10, 1998
    Assignee: SangStat Medical Corporation
    Inventors: Moo J. Cho, Ralph F. Levy, Philippe J. Pouletty
  • Patent number: 5780025
    Abstract: DNA isolates coding for enkephalinase and methods of obtaining such DNA are provided, together with expression systems for recombinant production of enkephalinase for use in therapeutic or diagnostic compositions. Enkephalinase assays are facilitated by novel enkephalinase substrates.
    Type: Grant
    Filed: October 12, 1993
    Date of Patent: July 14, 1998
    Assignee: Genentech, Inc.
    Inventors: Bernard Malfroy-Camine, Peter R. Schofield